Identification and validation of PCSK9 as a prognostic and immune-related influencing factor in tumorigenesis: a pan-cancer analysis

INTRODUCTION: Proprotein convertase subtilisin/kexin-9 (PCSK9) has been primarily studied in the cardiovascular field however, its role in cancer pathophysiology remains incompletely defined. Recently, a pivotal role for PCSK9 in cancer immunotherapy was proposed based on the finding that PCSK9 inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Chao, Zhu, Guoji, Shen, Conghuan, Huang, Shungen, Li, Ruidong, Li, Jianhua, Ma, Zhenyu, Wang, Zhengxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584329/
https://www.ncbi.nlm.nih.gov/pubmed/37860186
http://dx.doi.org/10.3389/fonc.2023.1134063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584329/
https://www.ncbi.nlm.nih.gov/pubmed/37860186
http://dx.doi.org/10.3389/fonc.2023.1134063

Ejemplares similares